Newer technologies/techniques and tools in the diagnosis of melanoma

European Journal of Dermatology

Volumn 18, Issue 6, 2008, Pages 617-631

  Patel, Jitendrakumar K ^a   Konda, Sailesh ^b   Perez, Oliver A ^b   Amini, Sadegh ^b   Elgart, George ^b   Berman, Brian ^b  

^a JAMAICA HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Dermoscope; Digital image analysis; Melanoma; MRI; PET scan; Ultrasound

Indexed keywords

DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1;

ARTIFICIAL NEURAL NETWORK; CLINICAL TRIAL; COMPUTER ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFOCAL LASER MICROSCOPY; DATA ANALYSIS SOFTWARE; DEVICE; DIAGNOSTIC ACCURACY; DIGITAL IMAGING; EARLY DIAGNOSIS; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; LASER DOPPLER FLOWMETRY; MEDICAL TECHNOLOGY; MELANOMA; MORBIDITY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY;

DERMATOLOGY; HUMANS; MELANOMA; SKIN NEOPLASMS;

EID: 57849097701     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0508     Document Type: Review

References (172)

1. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the american joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-48.
2. Wolf IH, Smolle J, Soyer HP, Kerl H. Sensitivity in the clinical diagnosis of malignant melanoma. Melanoma Res 1998; 8: 425-9.
3. Curley RK, Cook MG, Fallowfield ME, Marsden RA. Accuracy in clinically evaluating pigmented lesions. BMJ 1989; 299: 16-8.
4. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3: 159-65.
5. Ascierto PA, Palmieri G, Celentano E, et al. Sensitivity and specificity of epiluminescence microscopy: Evaluation on a sample of 2731 excised cutaneous pigmented lesions. the melanoma cooperative study. Br J Dermatol 2000; 142: 893-8.
6. Rubegni P, Cevenini G, Burroni M, et al. Automated diagnosis of pigmented skin lesions. Int J Cancer 2002; 101: 576-80.
7. Skvara H, Teban L, Fiebiger M, Binder M, Kittler H. Limitations of dermoscopy in the recognition of melanoma. Arch Dermatol 2005; 141: 155-60.
8. Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. pattern analysis of pigmented skin lesions. J Am Acad Dermatol 1987; 17: 571-83.
9. Binder M, Schwarz M, Winkler A, et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131: 286-91.
10. Asawanonda P, Taylor CR. Wood's light in dermatology. Int J Dermatol 1999; 38: 801-7.
11. Kopf AW, Salopek TG, Slade J, Marghoob AA, Bart RS. Techniques of cutaneous examination for the detection of skin cancer. Cancer 1995; 75: 684-90.
12. Chwirot BW, Chwirot S, Redzinski J, Michniewicz Z. Detection of melanomas by digital imaging of spectrally resolved ultraviolet light-induced autofluorescence of human skin. Eur J Cancer 1998; 34: 1730-4.
13. Church J, Williams H. Another sniffer dog for the clinic? Lancet 2001; 358: 930.
14. Balseiro SC, Correia HR. Is olfactory detection of human cancer by dogs based on major histocompatibility complex-dependent odour components?-A possible cure and a precocious diagnosis of cancer. Med Hypotheses 2006; 66: 270-2.
15. Williams H, Pembroke A. Sniffer dogs in the melanoma clinic? Lancet 1989; 1: 734.
16. Offidani A, Simonetti O, Bernardini ML, Alpagut A, Cellini A, Bossi G. General practitioners' accuracy in diagnosing skin cancers. Dermatology 2002; 205: 127-30.
17. Fleming MG. Digital dermoscopy. Dermatol Clin 2001; 19: 359-67; (ix).
18. Rubegni P, Burroni M, Andreassi A, Fimiani M. The role of dermoscopy and digital dermoscopy analysis in the diagnosis of pigmented skin lesions. Arch Dermatol 2005; 141: 1444-6.
19. Roesch A, Burgdorf W, Stolz W, Landthaler M, Vogt T. Dermatoscopy of "dysplastic nevi": A beacon in diagnostic darkness. Eur J Dermatol 2006; 16: 479-93.
20. Joel G, Schmid-Saugeon P, Guggisberg D, et al. Validation of segmentation techniques for digital dermoscopy. Skin Res Technol 2002; 8: 240-9.
21. Rubegni P, Burroni M, Dell'eva G, Andreassi L. Digital dermoscopy analysis for automated diagnosis of pigmented skin lesions. Clin Dermatol 2002; 20: 309-12.
22. Schindewolf T, Schiffner R, Stolz W, Albert R, Abmayr W, Harms H. Evaluation of different image acquisition techniques for a computer vision system in the diagnosis of malignant melanoma. J Am Acad Dermatol 1994; 31: 33-41.
23. Serup J. High-tech dermatology. Eur J Dermatol 2007; 17: 178-80.
24. Menzies SW, Bischof L, Talbot H, et al. The performance of SolarScan: An automated dermoscopy image analysis instrument for the diagnosis of primary melanoma. Arch Dermatol 2005; 141: 1388-96.
25. Burroni M, Corona R, Dell'Eva G, et al. Melanoma computer-aided diagnosis: Reliability and feasibility study. Clin Cancer Res 2004; 10: 1881-6.
26. Hoffmann K, Gambichler T, Rick A, et al. Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. Br J Dermatol 2003; 149: 801-9.
27. Lee TK, Claridge E. Predictive power of irregular border shapes for malignant melanomas. Skin Res Technol 2005; 11: 1-8.
28. Binder M, Kittler H, Dreiseitl S, Ganster H, Wolff K, Pehamberger H. Computer-aided epiluminescence microscopy of pigmented skin lesions: The value of clinical data for the classification process. Melanoma Res 2000; 10: 556-61.
29. Binder M, Steiner A, Schwarz M, Knollmayer S, Wolff K, Pehamberger H. Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: A pilot study. Br J Dermatol 1994; 130: 460-5.
30. Baxt WG, Shofer FS, Sites FD, Hollander JE. A neural network aid for the early diagnosis of cardiac: ischemia in patients presenting to the emergency department with chest pain. Ann Emerg Med 2002; 40: 575-83.
31. Itchhaporia D, Snow PB, Almassy RJ, Oetgen WJ. Artificial neural networks: Current status in cardiovascular medicine. J Am Coll Cardiol 1996; 28: 515-21.
32. Binder M, Kittler H, Seeber A, Steiner A, Pehamberger H, Wolff K. Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network. Melanoma Res 1998; 8: 261-6.
33. Moncrieff M, Cotton S, Claridge E, Hall P. Spectrophotometric intracutaneous analysis: A new technique for imaging pigmented skin lesions. Br J Dermatol 2002; 146: 448-57.
34. Elbaum M, Kopf AW, Rabinovitz HS, et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: A feasibility study. J Am Acad Dermatol 2001; 44: 207-18.
35. Gutkowicz-Krusin D, Elbaum M, Jacobs A, et al. Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind(TM) multispectral digital dermoscope. Melanoma Res 2000; 10: 563-70.
36. DermDOC. Available at: http://www.dermamedicalsystems.com. Accessed oct, 2006.
37. Dermascope. Available at: www.astronclinica.com. Accessed 10/05, 2006.
38. Michalska M, Chodorowska G, Krasowska D. SIAscopy-a new non-invasive technique of melanoma diagnosis. Ann Univ Mariae Curie Sklodowska [Med] 2004; 59: 421-31.
39. Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol 2001; 137: 1583-9.
40. SolarScan. Available at: www.polartechnics.com.au/index.htm. Accessed 10/ 10, 2006.
41. Menzies SW. Automated epiluminescence microscopy: Human vs machine in the diagnosis at melanoma. Arch Dermatol 1999; 135: 1538-40.
42. Kopf AW, Elbaum M, Provost N. The use of dermoscopy and digital imaging in the diagnosis of cutaneous malignant melanoma. Skin Res Technol 1997; 3: 1-7.
43. Morhenn VB, Chang EY, Rheins LA. A noninvasive method for quantifying and distinguishing inflammatory skin reactions. J Am Acad Dermatol 1999; 41(5 Pt 1): 687-92.
44. Berardi P, Arcangeli F. The tape stripping toluidine blue (TSTB) method in the diagnosis of malignant melanoma: An investigator-blind study. Melanoma Res 1992; 2(2): 93-9.
45. Wachsman W, Zapala M, Udall D, et al. Differentiation of Melanoma from Dysplastic Nevi in Suspicious Pigmented Skin Lesions by Non-invasive Tape Stripping. Available at: http://www.nugeninc.com/pdfs/ wachsman_sid_poster_la_2007.pdf. Accessed Aug/25, 2007.
46. Wachsman W, Hata T, Walls L, et al. Development of a multigene classifier to determine the risk of melanoma in suspicious pigmented nevi by non-invasive tape stripping. International investigative dermatology meeting 2008.
47. Hoffmann K, Jung J, el Gammal S, Altmeyer P. Malignant melanoma in 20-MHz B scan sonography. Dermatology 1992; 185: 49-55.
48. Hoffmann K, el Gammal S, Matthes U, Altmeyer P. Digital 20 mhz sonography of the skin in preoperative diagnosis. Z Hautkr 1989; 64: 851-2; (855-8).
49. Rallan D, Dickson M, Bush NL, Harland CC, Mortimer P, Bamber JC. High-resolution ultrasound reflex transmission imaging and digital photography: Potential tools for the quantitative assessment of pigmented lesions. Skin Res Technol 2006; 12: 50-9.
50. Moehrle M, Blum A, Rassner G, Juenger M. Lymph node metastases of cutaneous melanoma: Diagnosis by B-scan and color doppler sonography. J Am Acad Dermatol 1999; 41: 703-9.
51. Schmid-Wendtner MH, Burgdorf W. Ultrasound scanning in dermatology. Arch Dermatol 2005; 141: 217-24.
52. Cammarota T, Pinto F, Magliaro A, Sarno A. Current uses of diagnostic high-frequency US in dermatology. Eur J Radiol 1998; 27(Suppl 2): S215-S223.
53. Thiboutot DM. Dermatological Applications of High-Frequency Ultrasound. Available at: http://www.bioe.psu.edu/labs/NIH/derm_app.pdf. Accessed 02/ 17, 2007.
54. Gambichler T, Mousso G, Bahrenberg K, et al. Preoperative ultrasonic assessment of thin melanocytic skin lesions using a 100-MHz ultrasound transducer: A comparative study. Dermatol Surg 2007; 33: 818-24.
55. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: The role of high-resolution US. Radiology 1992; 183: 215-20.
56. Tregnaghi A, De Candia A, Calderone M, et al. Ultrasonographic evaluation of superficial lymph node metastases in melanoma. Eur J Radiol 1997; 24: 216-21.
57. Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G, Garbe C. Ultrasound examination at regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: Results of a prospective study of 1288 patients. Cancer 2000; 88: 2534-9.
58. Voit C, Mayer T, Kron M, et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 2001; 91: 2409-16.
59. Schmid-Wendtner MH, Paerschke G, Baumert J, Plewig G, Volkenandt M. Value of ultrasonography compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma. Melanoma Res 2003; 13: 183-8.
60. Garbe C, Paul A, Kohler-Spath H, et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy. J Clin Oncol 2003; 21: 520-9.
61. Busam KJ, Charles C, Lohmann CM, Marghoob A, Goldgeier M, Halpern AC. Detection of intraepidermal malignant melanoma in vivo by confocal scanning laser microscopy. Melanoma Res 2002; 12: 349-55.
62. Ono I, Sakemoto A, Ogino J, Kamiya T, Yamashita T, Jimbow K. The real-time, three-dimensional analyses of benign and malignant skin tumors by confocal laser scanning microscopy. J Dermatol Sci 2006; 43: 135-41.
63. Rajadhyaksha M, Gonzalez S, Zavislan JM, Anderson RR, Webb RH. In vivo confocal scanning laser microscopy of human skin II: Advances in instrumentation and comparison with histology. J Invest Dermatol 1999; 113: 293-303.
64. Delaney PM, King RG, Lambert JR, Harris MR. Fibre optic confocal imaging (FOCI) or subsurface microscopy of the colon in vivo. J Anat 1994; 184(Pt 1): 157-60.
65. Delaney PM, Harris MR, King RG. Novel microscopy using fibre optic confocal imaging and its suitability for subsurface blood vessel imaging in vivo. Clin Exp Pharmacol Physiol 1993; 20: 197-8.
66. Langley RG, Rajadhyaksha M, Dwyer PJ, Sober AJ, Flotte TJ, Anderson RR. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo. J Am Acad Dermatol 2001; 45: 365-76.
67. Langley RG, Burton E, Walsh N, Propperova I, Murray SJ. In vivo confocal scanning laser microscopy of benign lentigines: Comparison to conventional histology on in vivo characteristics of lentigo maligna. J Am Acad Dermatol 2006; 55: 88-97.
68. Meyer LE, Otberg N, Sterry W, Lademann J. In vivo confocal scanning laser microscopy: Comparison of the reflectance and fluorescence mode by imaging human skin. J Biomed Opt 2006; 11; (044012).
69. Busam KJ, Hester K, Charles C, et al. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy. Arch Dermatol 2001; 137: 923-9.
70. Rajadhyaksha M, Grossman M, Esterowitz D, Webb RH, Anderson RR. In vivo confocal scanning laser microscopy of human skin: Melanin provides strong contrast. J Invest Dermatol 1995; 104: 946-52.
71. Langley RG, Rajadhyaksha M, Dwyer PJ, Sober AJ, Flotte TJ, Anderson RR. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo. J Am Acad Dermatol 2001; 45: 365-76.
72. Kollias N, Stamatas GN. Optical non-invasive approaches to diagnosis of skin diseases. J Investig Dermatol Symp Proc 2002; 7: 64-75.
73. Mehrubeoglu M, Kehtarnavaz N, Marquez G, Duvic M, Wang LV. Skin lesion classification using oblique-incidence diffuse reflectance spectroscopic imaging. Appl Opt 2002; 41: 182-92.
74. Murphy BW, Webster RJ, Turlach BA, et al. Toward the discrimination of early melanoma from common and dysplastic nevus using fiber optic diffuse reflectance spectroscopy. J Biomed Opt 2005; 10; (064020).
75. Sokolov K, Nieman LT, Myakov A, Gillenwater A. Polarized reflectance spectroscopy for pre-cancer detection. Technol Cancer Res Treat 2004; 3: 1-14.
76. Gurjar RS, Backman V, Perelman LT, et al. Imaging human epithelial properties with polarized light-scattering spectroscopy. Nat Med 2001; 7: 1245-8.
77. Pellacani G, Guitera P, Longo C, Avramidis M, Seidenari S, Menzies S. The impact of in vivo reflectance confocal microscopy for the diagnostic accuracy of melanoma and equivocal melanocytic lesions. J Invest Dermatol 2007; 127: 2759-65.
78. Pellacani G, Cesinaro AM, Seidenari S. Reflectance-mode confocal microscopy of pigmented skin lesions-improvement in melanoma diagnostic specificity. J Am Acad Dermatol 2005; 53: 979-85.
79. Delaney PM, Harris MR, King RG. A fibre optic laser scanning confocal microscope suitable for fluorescence imaging. Opt 1994; 33: 573-7.
80. Anikijenko P, Vo LT, Murr ER, et al. In vivo detection of small subsurface melanomas in athymic mice using noninvasive fiber optic confocal imaging. J Invest Dermatol 2001; 117: 1442-8.
81. Welzel J. Optical coherence tomography in dermatology: A review. Skin Res Technol 2001; 7: 1-9.
82. Marchesini R, Tomatis S, Bartoli C, et al. In vivo spectrophotometric evaluation of neoplastic and non-neoplastic skin pigmented lesions. III. CCD camera-based reflectance imaging. Photochem Photobiol 1995; 62: 151-4.
83. Fujimoto JG, Bouma B, Tearney GJ, et al. New technology for high-speed and high-resolution optical coherence tomography. Ann N Y Acad Sci 1998; 838: 95-107.
84. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991; 254: 1178-81.
85. Marchesini R, Bono A, Bartoli C, Lualdi M, Tomatis S, Cascinelli N. Optical imaging and automated melanoma detection: Questions and answers. Melanoma Res 2002; 12: 279-86.
86. Schmitt JM, Yadlowsky MJ, Bonner RF. Subsurface imaging of living skin with optical coherence microscopy. Dermatology 1995; 191: 93-8.
87. Welzel J, Lankenau E, Birngruber R, Engelhardt R. Optical coherence tomography of the human skin. J Am Acad Dermatol 1997; 37: 958-63.
88. Vargas G, Chan EK, Barton JK, Rylander 3rd HG, Welch AJ. Use of an agent to reduce scattering in skin. Lasers Surg Med 1999; 24: 133-41.
89. Drexler W, Morgner U, Ghanta RK, Kartner FX, Schuman JS, Fujimoto JG. Ultrahigh-resolution ophthalmic optical coherence tomography. Nat Med 2001; 7: 502-7.
90. Veiro JA, Cummins PG. Imaging of skin epidermis from various origins using confocal laser scanning microscopy. Dermatology 1994; 189: 16-22.
91. Gambichler T, Mousso G, Sand M, Sand D, Altmeyer P, Hoffmann K. Applications of optical coherence tomography in dermatology. J Dermatol Sci 2005; 40: 85-94.
92. Pierce MC, Strasswimmer J, Park BH, Cense B, de Boer JF. Advances in optical coherence tomography imaging for dermatology. J Invest Dermatol 2004; 123: 458-63.
93. Zhao Y, Chen Z, Saxer C, Xiang S, de Boer JF, Nelson JS. Phase-resolved optical coherence tomography and optical doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity. Opt Lett. Washington DC, USA: Optical Society of America; 2000; 2: 114-116. Available from: http://www.opticsinfobase.org/ abstract.cfm?URI=ol-25-2-114. Accessed Feb-20-2007.
94. Chen Z, Milner TE, Wang X, Srinivas S, Nelson JS. Optical doppler tomography: Imaging in vivo blood flow dynamics following pharmacological intervention and photodynamic therapy. Photochem Photobiol 1998; 67: 56-60.
95. Fallowfield ME, Cook MG. The vascularity of primary cutaneous melanoma. J Pathol 1991; 164: 241-4.
96. Barnhill RL, Fandrey K, Levy MA, Mihm Jr. MC, Hyman B. Angiogenesis and tumor progression of melanoma quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 1992; 67: 331-7.
97. Konerding MA, van Ackern C, Steinberg F, Streffer C. Combined morphological approaches in the study of network formation in tumor angiogenesis. EXS 1992; 61: 40-58.
98. Ribatti D, Vacca A, Palma W, Lospalluti M, Dammacco F. Angiogenesis during tumor progression in human malignant melanoma. EXS 1992; 61: 415-20.
99. Tur E, Brenner S. Cutaneous blood flow measurements for the detection of malignancy in pigmented skin lesions. Dermatology 1992; 184: 8-11.
100. Braverman IM, Keh A, Goldminz D. Correlation of laser doppler wave patterns with underlying microvascular anatomy. J Invest Dermatol 1990; 95: 283-6.
101. Braverman IM, Schechner JS. Contour mapping of the cutaneous microvasculature by computerized laser doppler velocimetry. J Invest Dermatol 1991; 97: 1013-8.
102. Braverman IM, Schechner JS, Silverman DG, Keh-Yen A. Topographic mapping of the cutaneous microcirculation using two outputs of laser-doppler flowmetry: Flux and the concentration of moving blood cells. Microvasc Res 1992; 44: 33-48.
103. Wardell K, Braverman IM, Silverman DG, Nilsson GE. Spatial heterogeneity in normal skin perfusion recorded with laser doppler imaging and flowmetry. Microvasc Res 1994; 48: 26-38.
104. Stucker M, Esser M, Hoffmann M, et al. High-resolution laser doppler perfusion imaging aids in differentiating between benign and malignant melanocytic skin tumours. Acta Derm Venereol 2002; 82: 25-9.
105. Stucker M, Horstmann I, Nuchel C, Rochling A, Hoffmann K, Altmeyer P. Blood flow compared in benign melanocytic naevi, malignant melanomas and basal cell carcinomas. Clin Exp Dermatol 1999; 24: 107-11.
106. Stucker M, Springer C, Paech V, Hermes N, Hoffmann M, Altmeyer P. Increased laser doppler flow in skin tumors corresponds to elevated vessel density and reactive hyperemia. Skin Res Technol 2006; 12: 1-6.
107. Stucker M, Hoffmann M, Memmel U, von Bormann C, Hoffmann K, Altmeyer P. In vivo differentiation of pigmented skin tumors with laser doppler perfusion imaging. Hautarzt 2002; 53: 244-9.
108. Ilias MA, Wardell K, Stucker M, Anderson C, Salerud EG. Assessment of pigmented skin lesions in terms of blood perfusion estimates. Skin Res Technol 2004; 10: 43-9.
109. Aberg P, Nicander I, Hansson J, Geladi P, Holmgren U, Ollmar S. Skin cancer identification using multifrequency electrical impedance-a potential screening tool. IEEE Trans Biomed Eng 2004; 51: 2097-102.
110. Brown BH, Tidy JA, Boston K, Blackett AD, Smallwood RH, Sharp F. Relation between tissue structure and imposed electrical current flow in cervical neoplasia. Lancet 2000; 355: 892-5.
111. Zou Y, Guo Z. A review of electrical impedance techniques for breast cancer detection. Med Eng Phys 2003; 25: 79-90.
112. Wilkinson BA, Smallwood RH, Keshtar A, Lee JA, Hamdy FC. Electrical impedance spectroscopy and the diagnosis of bladder pathology: A pilot study. J Urol 2002; 168: 1563-7.
113. Blad B, Baldetorp B. Impedance spectra of tumour tissue in comparison with normal tissue; a possible clinical application for electrical impedance tomography. Physiol Meas 1996; 17(Suppl 4A): A105-A115.
114. Schwan HP. Electrical properties of tissue and cell suspensions. Adv Biol Med Phys 1957; 5: 147-209.
115. Foster KR, Schwan HP. Dielectric properties of tissues and biological materials: A critical review. Crit Rev Biomed Eng 1989; 17: 25-104.
116. Har-Shai Y, Glickman YA, Siller G, et al. Electrical impedance scanning for melanoma diagnosis: A validation study. Plast Reconstr Surg 2005; 116: 782-90.
117. Glickman YA, Filo O, David M, et al. Electrical impedance scanning: A new approach to skin cancer diagnosis. Skin Res Technol 2003; 9: 262-8.
118. Nicander I, Ollmar S. Electrical impedance measurements at different skin sites related to seasonal variations. Skin Res Technol 2000; 6: 81-6.
119. Aberg P, Geladi P, Nicander I, Ollmar S. Variation of skin properties within human forearms demonstrated by non-invasive detection and multi-way analysis. Skin Res Technol 2002; 8: 194-201.
120. Nicander I, Norlen L, Brockstedt U, Lundh Rozell B, Forslind B, Ollmar S. Electrical impedance and other physical parameters as related to lipid content of human stratum corneum. Skin Res Technol 1998; 4: 213-21.
121. Nicander I, Ollmar S, Eek A, Lundh Rozell B, Emtestam L. Correlation of impedance response patterns to histological findings in irritant skin reactions induced by various surfactants. Br J Dermatol 1996; 134: 221-8.
122. Aberg P, Geladi P, Nicander I, Hansson J, Holmgren U, Ollmar S. Non-invasive and microinvasive electrical impedance spectra of skin cancer - a comparison between two techniques. Skin Res Technol 2005; 11: 281-6.
123. Zemtsov A, Lorig R, Bergfield WF, Bailin PL, Ng TC. Magnetic resonance imaging of cutaneous melanocytic lesions. J Dermatol Surg Oncol 1989; 15: 854-8.
124. Zemtsov A, Lorig R, Ng TC, et al. Magnetic resonance imaging of cutaneous neoplasms: Clinicopathologic correlation. J Dermatol Surg Oncol 1991; 17: 416-22.
125. Takahashi M, Kohda H. Diagnostic utility of magnetic resonance imaging in malignant melanoma. J Am Acad Dermatol 1992; 27: 51-4.
126. Caldemeyer KS, Buckwalter KA. The basic principles of computed tomography and magnetic resonance imaging. J Am Acad Dermatol 1999; 41: 768-71.
127. Bittoun J, Saint-Jalmes H, Querleux BG, et al. In vivo high-resolution MR imaging of the skin in a whole-body system at 1.5 T. Radiology 1990; 176: 457-60.
128. Hawnaur JM, Dobson MJ, Zhu XP, Watson Y. Skin: MR imaging findings of middle field strength. Radiology 1996; 201: 868-72.
129. Hyde JS, Jesmanowicz A, Kneeland JB. Surface coil for MR imaging of the skin. Magn Reson Med 1987; 5: 456-61.
130. Zemtsov A, Lorig R, Bergfield WF, Bailin PL, Ng TC. Magnetic resonance imaging of cutaneous melanocytic lesions. J Dermatol Surg Oncol 1989; 15: 854-8.
131. Takahashi M, Kohda H. Diagnostic utility of magnetic resonance imaging in malignant melanoma. J Am Acad Dermatol 1992; 27: 51-4.
132. Maurer J, Knollmann FD, Schlums D, et al. Role of high-resolution magnetic resonance imaging for differentiating melanin-containing skin tumors. Invest Radiol 1995; 30: 638-43.
133. In: Warburg O, ed. The Metabolism of Tumours. New York: Richard Smith, 1931.
134. Warburg O, Wind F, Negelein E. On the metabolism of tumours in the body. In: Warburg O, ed. Metabolism of Tumours. London: Constable, 1930: 254-65.
135. Som P, Atkins HL, Bandoypadhyay D, et al. A fluorinated glucose analog 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21: 670-5.
136. Friedman KP, Wahl RL. Clinical use of positron emission tomography in the management of cutaneous melanoma. Semin Nucl Med 2004; 34: 242-53.
137. Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at memorial sloan-kettering cancer center. Dis Colon Rectum 1995; 38: 146-51.
138. Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol 2000; 12: 181-5.
139. Kotoulas C, Skagias L, Konstantinou G, et al. Primary pulmonary melanoma diagnosis: The role of immunohistochemistry and immunocytochemistry. J BUON 2007; 12: 543-5.
140. Bajer-Czajkowska A, Nowacki P. Primary diffuse meningeal melanomatosis, case report. Neurol Neurochir Pol 2007; 41: 82-8.
141. Steiber Z, Ehlers N, Heegaard S, Hjortdal J, Berta A, Prause JU. Brown cornea. Graefes Arch Clin Exp Ophthalmol 2008; 246 (4): 537-41.
142. Gupta D, Deavers MT, Silva EG, Malpica A. Malignant melanoma involving the ovary: A clinicopathologic and immunohistochemical study of 23 cases. Am J Surg Pathol 2004; 28: 771-80.
143. D'Silva NJ, Kurago Z, Polverini PJ, Hanks CT, Paulino AF. Malignant melanoma of the oral mucosa in a 17-year-old adolescent girl. Arch Pathol Lab Med 2002; 126: 1110-3.
144. Vlodavsky E, Ben-Izhak O, Best LA, Kerner H. Primary malignant melanoma of the anterior mediastinum in a child. Am J Surg Pathol 2000; 24: 747-9.
145. Rohwedder A, Philips B, Malfetano J, Kredentser D, Carlson JA. Vulvar malignant melanoma associated with human papillomavirus DNA: Report of two cases and review of literature. Am J Dermatopathol 2002; 24: 230-40.
146. Thompson, LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: A clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003; 27: 594-611.
147. Oliva E, Quinn TR, Amin MB, et al. Primary malignant melanoma of the urethra: A clinicopathologic analysis of 15 cases. Am J Surg Pathol 2000; 24: 785-96.
148. Gupta D, Malpica A, Deavers MT, Silva EG. Vaginal melanoma: A clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 2002; 26: 1450-7.
149. Phelps ME, Schelbert HR, Mazziotta JC. Positron computed tomography for studies of myocardial and cerebral function. Ann Intern Med 1983; 98: 339-59.
150. Leskinen-Kallio S, Ruotsalainen U, Nagren K, Teras M, Joensuu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-hodgkin's lymphoma: A PET study. J Nucl Med 1991; 32: 1211-8.
151. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992; 102: 281-8.
152. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170: 329-32.
153. Nagata Y, Yamamoto K, Hiraoka M, et al. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. J Comput Assist Tomogr 1990; 14: 370-4.
154. Griffeth LK, Dehdashti F, McGuire AH, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992; 182: 185-94.
155. Kubota K, Matsuzawa T, Ito M, et al. Lung tumor imaging by positron emission tomography using C-11 L-methionine. J Nucl Med 1985; 26: 37-42.
156. Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: Will it replace the other modalities? Semin Nucl Med 1997; 27: 94-106.
157. Boni R. Whole-body positron emission tomography: An accurate staging modality for metastatic melanoma. Arch Dermatol 1996; 132: 833-4.
158. Gerger A, Koller S, Kern T, et al. Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors. J Invest Dermatol 2005; 124: 493-8.
159. Gerger A, Koller S, Weger W, et al. Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors. Cancer 2006; 107: 193-200.
160. Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993; 34: 1420-7.
161. Steinert HC, Huch Boni RA, Buck A, et al. Malignant melanoma: Staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 195: 705-9.
162. Boni R, Boni RA, Steinert H, et al. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose. Br J Dermatol 1995; 132: 556-62.
163. Blessing C, Feine U, Geiger L, Carl M, Rassner G, Fierlbeck G. Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma. Arch Dermatol 1995; 131: 1394-8.
164. Wagner JD, Schauwecker D, Hutchins G, Coleman 3rd JJ. Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma. J Surg Oncol 1997; 612: 181-9.
165. Macfarlane DJ, Sondak V, Johnson T, Wahl RL. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. J Clin Oncol 1998; 16: 1770-6.
166. Rinne D, Baum RP, Hor G, Kaufmann R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: Results a a prospective study of 100 patients. Cancer 1998; 82: 1664-71.
167. Holder Jr. WD, White Jr. RL, ZugerJH, Easton Jr. EJ, Greene FL. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998; 227: 764-9; (discussion: 769-71).
168. Eigtved A, Andersson AP, Dahlstrom K, et al. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma. Eur J Nucl Med 2000; 27: 70-5.
169. Acland KM, O'Doherty W, Russell-Jones R. The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma. J Am Acad Dermatol 2000; 42: 606-11.
170. Swetter SM, Carroll LA, Johnson DL, Segall GM. Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. Ann Surg Oncol 2002; 9: 646-53.
171. Gulec SA, Faries MB, Lee CC, et al. The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: Impact on surgical decision making. Clin Nucl Med 2003; 28: 961-5.
172. Mottaghy FM, Sunderkotter C, Schubert R, et al. Direct comparison of [(18)F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma. Eur J Nucl Med Mol Imaging 2007; 34 (9): 1355-64.